Empfehlung
6,7
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
26.9
1 Insider, 75K $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Climb Bio, Inc. |
|---|---|
| Ticker | CLYM |
| CIK | 0001768446 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Climb Bio, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 10:48:07.515284 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | Thomas Stephen Basil | Director | Open Market Sale | -16,313 | 7.01 | -114,288.88 | -52,8% | |
| 2026-02-25 | Thomas Stephen Basil | Director | Open Market Sale | -33,687 | 7.00 | -235,963.96 | -109,1% | |
| 2026-02-13 | Thomas Stephen Basil | Director | Open Market Sale | -10,000 | 5.81 | -58,141.00 | -26,9% | |
| 2026-02-12 | Thomas Stephen Basil | Director | Open Market Sale | -90,000 | 5.23 | -470,988.00 | -217,7% | |
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 7,111 | 3.50 | 24,888.50 | +11,5% | |
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 7,111 | 3.50 | 24,888.50 | +11,5% | |
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 7,111 | 3.50 | 24,888.50 | +11,5% | |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 101,462 | 2.86 | 290,181.32 | +134,1% | |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 101,462 | 2.86 | 290,181.32 | +134,1% | |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 101,462 | 2.86 | 290,181.32 | +134,1% | |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 213,099 | 2.18 | 464,555.82 | +214,7% | |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 213,099 | 2.18 | 464,555.82 | +214,7% | |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 213,099 | 2.18 | 464,555.82 | +214,7% | |
| 2025-06-30 | Brennan Aoife | Director, Officer, President and CEO | Open Market Sale | -20,618 | 1.22 | -25,153.96 | -11,6% | |
| 2025-06-20 | Pimblett Emily | Officer, SVP, Finance & CAO | Open Market Sale | -1,242 | 1.24 | -1,540.08 | -0,7% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.